Product Information

TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.3678 per EA under NDC 62332020930. Its NADAC has been published 524 times since Aug 10, 2016.

FDA first approved this application on Feb 25, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB

Telmisartan and Hydrochlorothiazide
$0.3678per EA

Strength

12.5; 40 mg/1; mg/1

NDC

62332020930

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA203010

FDA Approved

2/25/2014

TE Code

AB

On Market Since

6/25/2016

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Increased Diuresis
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB has been published 524 times since Aug 10, 2016, and over the history we have for it it has declined 88.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3678 per EA
All-time high$3.2186 (Aug 10, 2016)
All-time low$0.2777 (Nov 20, 2024)
52-week high$0.4067
52-week low$0.3484
Median price$1.3518
Average price$1.3034
Largest weekly change+83.5% (Nov 22, 2023)
Weeks tracked524
Tracking sinceAug 10, 2016

Price History

1W

+3.2%

1M

+3.2%

3M

+1.4%

6M

-4.6%

1Y

-9.5%

3Y

-13.8%

5Y

-78.1%

All

-88.6%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB?

The current National Average Drug Acquisition Cost (NADAC) for TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB, manufactured by Alembic Pharmaceuticals Inc., is $0.3678 per EA (NDC 62332020930), effective Aug 19, 2026.

How has the price of TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB changed over time?

Over the history we have for it, the NADAC for TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB has declined 88.6%. It has been tracked across 524 weekly CMS publications since Aug 10, 2016.

What are the highest and lowest recorded NADAC prices for TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB?

Since Aug 10, 2016, the NADAC for TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB has ranged from a low of $0.2777 (Nov 20, 2024) to a high of $3.2186 (Aug 10, 2016), with a median of $1.3518 per EA.

Are there cheaper alternatives to TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB in a comparable dosage form, but none are currently priced below it.

Who manufactures TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB?

TELMISARTAN-HYDROCHLOROTHIAZIDE 40-12.5 MG TB (NDC 62332020930) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.